Gene · 406909
Papers2,249
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,249
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Circulating microRNAs as diagnostic biomarkers for ischemic stroke: evidence from comprehensive analysis and real-world validation. | Int J Med Sci | 2023 | 37484808 | PubTator, text mining | PubMed |
| Cerebrospinal fluid microRNAs as potential biomarkers in Alzheimer's disease. | Front Aging Neurosci | 2023 | 37476007 | PubTator, text mining | PubMed |
Retracted: Long Noncoding RNA Zinc Finger Antisense 1 Affects Glucocorticoid-Induced Osteonecrosis of the Femoral Head by Performing as a ceRNA for MicroRNA-124-3p and Accelerating Transforming Growth Factor Type III Receptor. | Comput Math Methods Med | 2023 | 37475934 | PubTator, text mining | PubMed |
| The role of Extracellular Genomic Materials (EGMs) in psychiatric disorders. | Transl Psychiatry | 2023 | 37464177 | PubTator, text mining | PubMed |
| MicroRNA-335-5p suppresses voltage-gated sodium channel expression and may be a target for seizure control. | Proc Natl Acad Sci U S A | 2023 | 37463203 | PubTator, text mining | PubMed |
| Chemotherapy-induced exosomal circBACH1 promotes breast cancer resistance and stemness via miR-217/G3BP2 signaling pathway. | Breast Cancer Res | 2023 | 37461019 | PubTator, text mining | PubMed |
| lncRNA XIST inhibition promotes M2 polarization of microglial and aggravates the spinal cord injury via regulating miR-124-3p / IRF1 axis. | Heliyon | 2023 | 37455998 | PubTator, text mining | PubMed |
| A comprehensive overview of exosome lncRNAs: emerging biomarkers and potential therapeutics in endometriosis. | Front Endocrinol (Lausanne) | 2023 | 37455911 | PubTator, text mining | PubMed |
| The role of long noncoding RNA H19 in gynecological pathologies: Insights into gene regulation and immune modulation (Review). | Int J Mol Med | 2023 | 37449492 | PubTator, text mining | PubMed |
| "DEPHENCE" system-a novel regimen of therapy that is urgently needed in the high-grade serous ovarian cancer-a focus on anti-cancer stem cell and anti-tumor microenvironment targeted therapies. | Front Oncol | 2023 | 37448521 | PubTator, text mining | PubMed |
| miRNAs in Neurological Manifestation in Patients Co-Infected with SARS-CoV-2 and Herpesvírus 6 (HHV-6). | Int J Mol Sci | 2023 | 37446381 | PubTator, text mining | PubMed |
| Role of MicroRNAs in Cancer Development and Treatment. | Int J Mol Sci | 2023 | 37446236 | PubTator, text mining | PubMed |
| Cerebrospinal Fluid Biomarkers for Diagnosis and the Prognostication of Acute Ischemic Stroke: A Systematic Review. | Int J Mol Sci | 2023 | 37446092 | PubTator, text mining | PubMed |
| Evaluation of a Set of miRNAs in 26 Cases of Fatal Traumatic Brain Injuries. | Int J Mol Sci | 2023 | 37446013 | PubTator, text mining | PubMed |
| Circulating miRNAs Expression in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. | Int J Mol Sci | 2023 | 37445763 | PubTator, text mining | PubMed |
| Insights into the Role of LncRNAs and miRNAs in Glioma Progression and Their Potential as Novel Therapeutic Targets. | Cancers (Basel) | 2023 | 37444408 | PubTator, text mining | PubMed |
| Recent Advances in Extracellular Vesicles in Amyotrophic Lateral Sclerosis and Emergent Perspectives. | Cells | 2023 | 37443797 | PubTator, text mining | PubMed |
| A potential posttranscriptional regulator for p60-katanin: miR-124-3p. | Cytoskeleton (Hoboken) | 2023 | 37439368 | PubTator, text mining | PubMed |
| Advances in Immunomodulatory Mechanisms of Mesenchymal Stem Cells-Derived Exosome on Immune Cells in Scar Formation. | Int J Nanomedicine | 2023 | 37427367 | PubTator, text mining | PubMed |
| Inflammation in multiple system atrophy. | Front Immunol | 2023 | 37426656 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406909/papers?page=18